AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2014
May 6, 2014
3174_iss_2014-05-06_976010c8-b8e5-4a89-861f-5ee1f4e47da4.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Grandeur Peak Global Advisors, LLC
Instrument
| Instrument | Common SE0003613090 |
|---|---|
| Before the transaction | |
| Shares | 592,651 |
| Voting rights | 592,651 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 02/05/2014 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 597,589 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 597,589 |
| Percentage | |
| Directly held shares | 5.02 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 5.02 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares |
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total
Chain of controlling companies
Voting rights % Voting rights Company
| 245,880 | 2.1 | Grandeur Peak Global Opportunities Fund |
|---|---|---|
| 264,938 | 2.2 | Grandeur Peak International Opportunities Fund |
| 63,419 | 0.5 | Grandeur Peak Global Opportunities L.P. |
| 23,352 | 0.2 | Grandeur Peak Global Reach Fund |
Group total holdings
Voting rights 597,589 Percentage of voting rights 5.02
Published
06/05/2014 09:42
Contact
Name Amy Hone Phone +1 801 384 0007 Email [email protected]
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13